PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Dulaglutide
Presentation Product Chemical substance Chapter Items dispensed
Trulicity 1.5mg/0.5ml solution for injection pre-filled pens
0601023AQBBABAB
Trulicity Dulaglutide Endocrine System 98,550
Dulaglutide 1.5mg/0.5ml inj pre-filled disposable devices
0601023AQAAABAB
Dulaglutide Dulaglutide Endocrine System 39,324
Trulicity 3mg/0.5ml solution for injection pre-filled pens
0601023AQBBACAC
Trulicity Dulaglutide Endocrine System 37,456
Trulicity 0.75mg/0.5ml inj pre-filled pens
0601023AQBBAAAA
Trulicity Dulaglutide Endocrine System 20,368
Trulicity 4.5mg/0.5ml solution for injection pre-filled pens
0601023AQBBADAD
Trulicity Dulaglutide Endocrine System 19,339
Dulaglutide 0.75mg/0.5ml inj pre-filled disposable devices
0601023AQAAAAAA
Dulaglutide Dulaglutide Endocrine System 7,224
Dulaglutide 3mg/0.5ml inj pre-filled disposable devices
0601023AQAAACAC
Dulaglutide Dulaglutide Endocrine System 6,224
Dulaglutide 4.5mg/0.5ml inj pre-filled disposable devices
0601023AQAAADAD
Dulaglutide Dulaglutide Endocrine System 2,742

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.